Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women

American Journal of Epidemiology

Volumn 178, Issue 2, 2013, Pages 231-238

  McMullan, Ciaran J ^a   Curhan, Gary C ^a   Schernhammer, Eva S ^a   Forman, John P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

6 sulfatoxymelatonin; circadian rhythm; cross sectional analysis; diabetes mellitus, type 2; insulin resistance; melatonin; premenopause

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; CHOLESTEROL; CREATININE; MELATONIN; URIC ACID;

ABNORMALITY; AGE CLASS; BLOOD; BODY MASS; DIET; DISEASE PREVALENCE; GENE EXPRESSION; HEALTH IMPACT; HORMONE; METABOLITE; NOCTURNAL ACTIVITY; POLYMORPHISM; REPRODUCTIVE HEALTH; SECRETION; SMOKING; URINE; WOMENS HEALTH; YOUNG POPULATION;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CREATININE URINE LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ESTIMATED GLOMERULAR FILTRATION RATE; FAMILY HISTORY; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC INDEX; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LONGITUDINAL STUDY; MICTURITION; NORMAL HUMAN; PHYSICAL ACTIVITY; SMOKING; UNITED STATES; URIC ACID BLOOD LEVEL;

6-SULFATOXYMELATONIN; CIRCADIAN RHYTHM; CROSS-SECTIONAL ANALYSIS; DIABETES MELLITUS, TYPE 2; INSULIN RESISTANCE; MELATONIN; PREMENOPAUSE;

ADULT; BIOLOGICAL MARKERS; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; MELATONIN; MIDDLE AGED; ODDS RATIO;

UNITED STATES;

ANIMALIA;

EID: 84880544722     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws470     Document Type: Article

References (42)

1. Waldhauser F, Dietzel M. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann N Y Acad Sci. 1985;453(1):205-214. (Pubitemid 16169260)
2. Claustrat B, Brun J, Chazot G. The basic physiology and pathophysiology of melatonin. Sleep Med Rev. 2005; 9(1):11-24. (Pubitemid 40092915)
3. Kemp DM, Ubeda M, Habener JF. Identification and functional characterization of melatonin Mel 1a receptors in pancreatic beta cells: potential role in incretin-mediated cell function by sensitization of cAMP signaling. Mol Cell Endocrinol. 2002;191(2):157-166. (Pubitemid 34626621)
4. Ramracheya RD, Muller DS, Squires PE, et al. Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res. 2008;44(3):273-279. (Pubitemid 351392941)
5. Prunet-Marcassus B, Desbazeille M, Bros A, et al. Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology. 2003;144(12): 5347-5352. (Pubitemid 37476063)
6. Nduhirabandi F, Du Toit EF, Blackhurst D, et al. Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity. J Pineal Res. 2011;50(2): 171-182.
7. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet. 2009;41(1):89-94.
8. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet. 2009; 41(1):77-81.
9. 1(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010; 59(12):3229-3239.
10. Hikichi T, Tateda N, Miura T. Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy. Clin Ophthalmol. 2011;5:655-660.
11. Mäntele S, Otway DT, Middleton B, et al. Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic men. PLoS One. 2012;7(5):e37123.
12. Corbalán-Tutau D, Madrid JA, Nicolás F, et al. Daily profile in two circadian markers "melatonin and cortisol" and associations with metabolic syndrome components [published online ahead of print June 13, 2012]. Physiol Behav. 2012. (doi:10.1016/j.physbeh.2012.06.005).
13. Rich-Edwards JW, Goldman MB, Willett WC, et al. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol. 1994;171(1): 171-177. (Pubitemid 24254437)
14. Forman JP, Choi H, Curhan GC. Uric acid and insulin sensitivity and risk of incident hypertension. Arch Intern Med. 2009;169(2):155-162.
15. Graham C, Cook MR, Kavet R, et al. Prediction of nocturnal plasma melatonin from morning urinary measures. J Pineal Res. 1998;24(4):230-238. (Pubitemid 28206444)
16. Baskett JJ, Cockrem JF, Antunovich TA. Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function. J Pineal Res. 1998;24(1):58-61. (Pubitemid 28161022)
17. Masue T, Wada K, Hayashi M, et al. Associations of urinary 6-sulfatoxymelatonin with biomarkers related to cardiovascular disease in Japanese women. Metabolism. 2012;61(1):70-75.
18. Forman JP, Curhan GC, Schernhammer ES. Urinary melatonin and risk of incident hypertension among young women. J Hypertens. 2010;28(3):446-451.
19. Sakotnik A, Liebmann PM, Stoschitzky K, et al. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J. 1999;20(18):1314-1317. (Pubitemid 29429717)
20. McAuley KA, Williams SM, Mann JI, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24(3):460-464. (Pubitemid 32198413)
21. Ascaso JF, Pardo S, Real JT, et al. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26(12): 3320-3325. (Pubitemid 37466894)
22. Tipene-Leach D, Pahau H, Joseph N, et al. Insulin resistance in a rural Maori community. N Z Med J. 2004;117(1207):U1208.
23. Mann JI, Tipene-Leach DC, Pahau HL, et al. Insulin resistance and impaired glucose metabolism in a predominantly Maori community. Diabetes Res Clin Pract. 2006;72(1):68-74.
24. Lorenzo C, Haffner SM, Stancáková A, et al. Relation of direct and surrogate measures of insulin resistance to cardiovascular risk factors in nondiabetic Finnish offspring of type 2 diabetic individuals. J Clin Endocrinol Metab. 2010; 95(11):5082-5090.
25. Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol. 1994;23(5):991-999. (Pubitemid 24331214)
26. Cho E, Spiegelman D, Hunter DJ, et al. Premenopausal dietary carbohydrate, glycemic index, glycemic load, and fiber in relation to risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2003;12(11):1153-1158. (Pubitemid 37499437)
27. Giovannucci E, Colditz G, Stampfer MJ, et al. The assessment of alcohol consumption by a simple self-administered questionnaire. Am J Epidemiol. 1991;133(8):810-817.
28. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122(1):51-65. (Pubitemid 15010435)
29. Rimm EB, Giovannucci EL, Stampfer MJ, et al. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135(10): 1114-1126.
30. Salmerón J, Manson JE, Stampfer MJ, et al. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA. 1997;277(6):472-477. (Pubitemid 27074331)
31. Jenkins DJ, Wolever TM, Taylor RH, et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr. 1981;34(3):362-366. (Pubitemid 11159124)
32. Wolever TM, Nguyen PM, Chiasson JL, et al. Determinants of diet glycemic index calculated retrospectively from diet records of 342 individuals with non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1994;59(6):1265-1269.
33. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150(9):604-612.
34. Pan A, Schernhammer ES, Sun Q, et al. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med. 2011;8(12):e1001141.
35. Peschke E, Fauteck JD, Musshoff U, et al. Evidence for a melatonin receptor within pancreatic islets of neonate rats: functional, autoradiographic, and molecular investigations. J Pineal Res. 2000;28(3):156-164. (Pubitemid 30162447)
36. Bonnefond A, Clément N, Fawcett K, et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet. 2012;44(3):297-301.
37. Peschke E, Frese T, Chankiewitz E, et al. Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status. J Pineal Res. 2006;40(2): 135-143.
38. Plantinga L, Rao MN, Schillinger D. Prevalence of self-reported sleep problems among people with diabetes in the United States, 2005-2008. Prev Chronic Dis. 2012;9:E76.
39. Hernández C, Abreu J, Abreu P, et al. Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP. Eur Respir J. 2007;30(3):496-500. (Pubitemid 351182073)
40. Ayas NT, White DP, Al-Delaimy WK, et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 2003;26(2): 380-384. (Pubitemid 36929059)
41. Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care. 2006;29(3):657-661. (Pubitemid 44115369)
42. Ruige JB, Mertens IL, Bartholomeeusen E, et al. Fasting-based estimates of insulin sensitivity in overweight and obesity: a critical appraisal. Obesity (Silver Spring). 2006; 14(7):1250-1256. (Pubitemid 46219691)